Randomized Trial of a WeChat Applet to Improve Symptoms and Adherence to Oral Therapy for gastrointestinal Cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058189

Enrollment

Unknown

Registered

2022-04-01

Start date

2022-05-01

Completion date

Unknown

Last updated

2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumor

Interventions

Intervention Group:Wechat applet pharmaceutical care

Control Group:Traditional pharmaceutical care

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients were diagnosed with gastrointestinal tumors treated with oral antitumor drugs; 2. Patients have the ability to use wechat applet.

Exclusion criteria

Exclusion criteria: 1. Patients don't have smart phones; 2. Patients are unwilling to accept the trial.

Design outcomes

Primary

Measure	Time frame
Medication adherence;Quality of life;Adverse drug reactions;	—

Secondary

Measure	Time frame
Social ability scale;	—

Countries

China

Contacts

Public ContactChenxu Ni

Shanghai Tenth People's Hospital

nichenxu@126.com+86 134524506143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026